18/06/2026
As part of our continuous journey toward growth, innovation, and regulatory excellence, and in line with Gypto Pharma’s ongoing FDA-readiness development, specialized training sessions were conducted for relevant Subject Matter Experts at Gypto Pharma by the U.S. team and our expert GMP/FDA consultant, Maria.
The training focused on strengthening operational excellence, reinforcing data integrity practices, enhancing quality standards, and supporting alignment with international regulatory expectations.
At Dawah Pharma, we remain committed to continuous improvement, knowledge development, and building a future driven by quality, compliance, and innovation.
